Download PDF

Other users also viewed these articles

Control of proteinuria with increased doses of agalsidase alfa in a patient with Fabry disease with atypical genotype–phenotype expression Christos Paliouras, Georgios Aperis, Foteini Lamprianou, Giorgos Ntetskas, Konstantinos Roufas, Polichronis Alivanis
10.1016/j.nefroe.2015.09.009
Fabry disease as a trigger of immune-mediated glomerular disease: Clinical hypotheses and literature review Javier Martínez de Victoria Carazo, Haylen Marin, Francisco Javier De la Hera Fernández, Carlos Mañero Rodríguez, César Ramírez Tortosa, José Luís Callejas Rubio
10.1016/j.nefroe.2025.04.010
Podocyturia in pediatric patients with Fabry disease Miguel Liern, Anabella Collazo, Maylin Valencia, Alejandro Fainboin, Lorena Isse, Cristian Costales-Collaguazo, Federico Ochoa, Graciela Vallejo, Elsa Zotta
10.1016/j.nefroe.2019.03.001